Lilly Xu is a seasoned executive in the biotechnology and pharmaceutical industries, currently serving as Chief Technology Officer at Medicilon Inc. since November 2024. Previously, Lilly held prominent roles at ChemPartner from April 2017 to April 2024, including President, where responsibilities included managing the CRO business and overseeing a team of 500 scientists, as well as guiding clients through drug discovery. Earlier career highlights include leadership positions at Sanofi, Amgen, Purdue Pharma L.P., and Neurogen Corporation, focusing on drug metabolism, pharmacokinetics, and ADMET research. Lilly Xu earned a Ph.D. in Cell and Molecular Biology from Saint Louis University School of Medicine.
This person is not in any teams
This person is not in any offices